Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 22 studies | 94% ± 13% | |
lung | 20 studies | 87% ± 17% | |
brain | 18 studies | 50% ± 25% | |
intestine | 13 studies | 92% ± 15% | |
eye | 11 studies | 76% ± 18% | |
kidney | 9 studies | 89% ± 17% | |
liver | 8 studies | 74% ± 22% | |
lymph node | 6 studies | 99% ± 1% | |
heart | 6 studies | 35% ± 18% | |
pancreas | 5 studies | 85% ± 25% | |
bone marrow | 5 studies | 94% ± 10% | |
placenta | 5 studies | 73% ± 33% | |
uterus | 5 studies | 95% ± 9% | |
prostate | 5 studies | 72% ± 34% | |
adipose | 4 studies | 57% ± 31% | |
esophagus | 4 studies | 79% ± 23% | |
breast | 4 studies | 98% ± 3% | |
adrenal gland | 3 studies | 84% ± 19% | |
skin | 3 studies | 83% ± 22% | |
stomach | 3 studies | 79% ± 17% | |
thymus | 3 studies | 79% ± 30% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 326725.57 | 1445 / 1445 | 100% | 1065.09 | 183 / 183 |
ovary | 100% | 562739.93 | 180 / 180 | 100% | 1860.77 | 430 / 430 |
pancreas | 100% | 323362.05 | 328 / 328 | 100% | 1276.08 | 178 / 178 |
prostate | 100% | 323850.98 | 245 / 245 | 100% | 2042.34 | 502 / 502 |
intestine | 100% | 337373.88 | 966 / 966 | 100% | 1699.97 | 525 / 527 |
lung | 100% | 282535.33 | 577 / 578 | 100% | 1440.32 | 1152 / 1155 |
breast | 100% | 386084.92 | 459 / 459 | 100% | 1730.00 | 1113 / 1118 |
thymus | 100% | 303805.05 | 653 / 653 | 100% | 2382.10 | 602 / 605 |
stomach | 100% | 257756.53 | 359 / 359 | 99% | 1392.38 | 284 / 286 |
uterus | 100% | 416547.43 | 170 / 170 | 99% | 1260.14 | 454 / 459 |
bladder | 100% | 388452.48 | 21 / 21 | 99% | 1301.11 | 498 / 504 |
kidney | 100% | 316271.85 | 89 / 89 | 98% | 1764.43 | 884 / 901 |
skin | 100% | 458544.44 | 1809 / 1809 | 98% | 1481.61 | 462 / 472 |
brain | 97% | 112719.06 | 2555 / 2642 | 100% | 1543.52 | 703 / 705 |
adrenal gland | 100% | 302049.36 | 258 / 258 | 91% | 843.05 | 210 / 230 |
liver | 95% | 102742.83 | 214 / 226 | 94% | 781.42 | 380 / 406 |
adipose | 100% | 394341.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 339557.87 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 1849.04 | 29 / 29 |
spleen | 100% | 253255.13 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 1240.79 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 493.72 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 2064.09 | 79 / 80 |
peripheral blood | 94% | 279677.31 | 871 / 929 | 0% | 0 | 0 / 0 |
heart | 76% | 104938.28 | 653 / 861 | 0% | 0 | 0 / 0 |
muscle | 38% | 39011.32 | 305 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1900022 | Biological process | regulation of D-erythro-sphingosine kinase activity |
GO_1904714 | Biological process | regulation of chaperone-mediated autophagy |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0044829 | Biological process | positive regulation by host of viral genome replication |
GO_0006412 | Biological process | translation |
GO_0006414 | Biological process | translational elongation |
GO_0005853 | Cellular component | eukaryotic translation elongation factor 1 complex |
GO_0032587 | Cellular component | ruffle membrane |
GO_0005730 | Cellular component | nucleolus |
GO_0005615 | Cellular component | extracellular space |
GO_0022626 | Cellular component | cytosolic ribosome |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005840 | Cellular component | ribosome |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0030864 | Cellular component | cortical actin cytoskeleton |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0098574 | Cellular component | cytoplasmic side of lysosomal membrane |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0019900 | Molecular function | kinase binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005525 | Molecular function | GTP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0000049 | Molecular function | tRNA binding |
GO_0003746 | Molecular function | translation elongation factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | EEF1A1 |
Protein name | Elongation factor 1-alpha 1 EEF1A1 protein Elongation factor 1-alpha Elongation factor 1-alpha 1 (EF-1-alpha-1) (EC 3.6.5.-) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7) |
Synonyms | hCG_2033271 EF1A LENG7 EEF1A |
Description | FUNCTION: Translation elongation factor that catalyzes the GTP-dependent binding of aminoacyl-tRNA (aa-tRNA) to the A-site of ribosomes during the elongation phase of protein synthesis . Base pairing between the mRNA codon and the aa-tRNA anticodon promotes GTP hydrolysis, releasing the aa-tRNA from EEF1A1 and allowing its accommodation into the ribosome . The growing protein chain is subsequently transferred from the P-site peptidyl tRNA to the A-site aa-tRNA, extending it by one amino acid through ribosome-catalyzed peptide bond formation . Also plays a role in the positive regulation of IFNG transcription in T-helper 1 cells as part of an IFNG promoter-binding complex with TXK and PARP1 . .; FUNCTION: (Microbial infection) Required for the translation of viral proteins and viral replication during human coronavirus SARS-CoV-2 infection. . FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. . FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. . FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. . FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. . FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. . FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. . FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. . FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. . |
Accessions | Q6IPS9 Q6NSH7 A0A087WV01 A6PW80 ENST00000678515.1 ENST00000610520.5 A0A087WVQ9 ENST00000331523.7 A0A7I2V5N4 ENST00000455918.2 Q6P4C9 ENST00000678703.1 ENST00000309268.11 ENST00000678702.1 A0A7I2V659 ENST00000678508.1 Q6IPN6 ENST00000676547.1 Q6P082 Q6NS35 A0A7I2V3H3 ENST00000615060.5 ENST00000676710.1 ENST00000455918 ENST00000677236.1 ENST00000356303 ENST00000615060 ENST00000356303.7 Q6IPT9 Q5JR01 ENST00000316292.13 Q504Z0 Q96EB3 P68104 |